Nie et al. identified TLR2, TREM1, CXCR1, FPR1, and FPR2 as promising candidates for predicting anti-TNFα responses in CD patients by microarray analysis (Nie et al., 2022). The gene discussed is TNF; the disease is Cowden disease.